Drugs / LXR015-1
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00002365 | — | HIV infectious disease | LXR Biotechnology | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LXR015-1 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00002365 ↗ |
| Route | Oral | “oral LXR015-1” NCT00002365 ↗ |